Literature DB >> 17062647

Rheumatoid synovial endothelial cells produce macrophage colony-stimulating factor leading to osteoclastogenesis in rheumatoid arthritis.

K Nakano1, Y Okada, K Saito, R Tanikawa, N Sawamukai, Y Sasaguri, T Kohro, Y Wada, T Kodama, Y Tanaka.   

Abstract

OBJECTIVES: Periarticular osteoporosis and joint destruction are major complications in rheumatoid arthritis (RA), caused by osteoclast-mediated bone resorption. However, the mechanisms of monocyte/osteoclast maturation and role of RA endothelial cells (RAECs) in the control of osteoclastogenesis remain unclear. The present study was designed to determine the most important factors that influence monocyte accumulation and osteoclast formation among the many factors produced by RAEC.
METHODS: We analysed the expression profiles of various genes in human endothelial cells from various organs (RA synovium, umbilical vein, skin, liver sinusoid, renal glomerulus and brain) using oligonucleotide microarrays. Specifically, up-regulated gene in RAECs was assessed by real-time quantitative polymerase chain reaction, enzyme-linked immunosorbent assay and immunostaining of RA synovia. Migration of monocytes was assessed by the chemotactic chamber EZ-TAXIScan. Tartrate-resistant acid phosphatase (TRAP)-positive multinucleated cell (MNC) formation was observed by microscopy.
RESULTS: Among many epithelial-expressed factors, macrophage colony-stimulating factor (M-CSF) gene was abundantly expressed specifically in RAECs. Genes of fibroblast growth factor-2, interleukin-6 and osteoprotegerin were also overexpressed in RAECs. Migration of monocytes and osteoclast formation in co-cultures promoted by culture supernatants of RAECs were inhibited by M-CSF neutralizing antibody.
CONCLUSIONS: M-CSF produced by RAECs is involved in osteoclastogenesis from monocytes, migration and TRAP-positive MNC formation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17062647     DOI: 10.1093/rheumatology/kel356

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  14 in total

Review 1.  [New biologics and orally available compounds. What is still in the pipeline?].

Authors:  M Grünke; H Bastian; H Schulze-Koops; G-R Burmester
Journal:  Z Rheumatol       Date:  2010-09       Impact factor: 1.372

Review 2.  Tyrosine kinases as targets for the treatment of rheumatoid arthritis.

Authors:  Christina D'Aura Swanson; Ricardo T Paniagua; Tamsin M Lindstrom; William H Robinson
Journal:  Nat Rev Rheumatol       Date:  2009-06       Impact factor: 20.543

3.  Distinct degenerative phenotype of articular cartilage from knees with meniscus tear compared to knees with osteoarthritis.

Authors:  M F Rai; E D Tycksen; L Cai; J Yu; R W Wright; R H Brophy
Journal:  Osteoarthritis Cartilage       Date:  2019-02-21       Impact factor: 6.576

4.  Imatinib inhibits CSF1R that stimulates proliferation of rheumatoid arthritis fibroblast-like synoviocytes.

Authors:  X Hu; J Tang; X Hu; P Bao; J Pan; Y Ou; W Deng; Y Liang
Journal:  Clin Exp Immunol       Date:  2018-10-23       Impact factor: 4.330

5.  c-Fms-mediated differentiation and priming of monocyte lineage cells play a central role in autoimmune arthritis.

Authors:  Ricardo T Paniagua; Anna Chang; Melissa M Mariano; Emily A Stein; Qian Wang; Tamsin M Lindstrom; Orr Sharpe; Claire Roscow; Peggy P Ho; David M Lee; William H Robinson
Journal:  Arthritis Res Ther       Date:  2010-02-24       Impact factor: 5.156

6.  Mavrilimumab, a human monoclonal antibody targeting GM-CSF receptor-α, in subjects with rheumatoid arthritis: a randomised, double-blind, placebo-controlled, phase I, first-in-human study.

Authors:  Gerd R Burmester; Eugen Feist; Matthew A Sleeman; Bing Wang; Barbara White; Fabio Magrini
Journal:  Ann Rheum Dis       Date:  2011-05-25       Impact factor: 19.103

7.  Expression of colony-stimulating factor 1 is associated with occurrence of osteochondral change in pigmented villonodular synovitis.

Authors:  Takehiro Ota; Hiroshi Urakawa; Eiji Kozawa; Kunihiro Ikuta; Shunsuke Hamada; Satoshi Tsukushi; Yoshie Shimoyama; Naoki Ishiguro; Yoshihiro Nishida
Journal:  Tumour Biol       Date:  2015-02-18

8.  Wear particles derived from metal hip implants induce the generation of multinucleated giant cells in a 3-dimensional peripheral tissue-equivalent model.

Authors:  Debargh K Dutta; Pushya A Potnis; Kelly Rhodes; Steven C Wood
Journal:  PLoS One       Date:  2015-04-20       Impact factor: 3.240

9.  SH3BP2 gain-of-function mutation exacerbates inflammation and bone loss in a murine collagen-induced arthritis model.

Authors:  Tomoyuki Mukai; Richard Gallant; Shu Ishida; Teruhito Yoshitaka; Mizuho Kittaka; Keiichiro Nishida; David A Fox; Yoshitaka Morita; Yasuyoshi Ueki
Journal:  PLoS One       Date:  2014-08-21       Impact factor: 3.240

10.  Identification of a novel arthritis-associated osteoclast precursor macrophage regulated by FoxM1.

Authors:  Tetsuo Hasegawa; Junichi Kikuta; Takao Sudo; Yoshinobu Matsuura; Takahiro Matsui; Szandor Simmons; Kosuke Ebina; Makoto Hirao; Daisuke Okuzaki; Yuichi Yoshida; Atsushi Hirao; Vladimir V Kalinichenko; Kunihiro Yamaoka; Tsutomu Takeuchi; Masaru Ishii
Journal:  Nat Immunol       Date:  2019-11-18       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.